TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Why Does Canopy Growth Corp. Avoid Releasing This Most-Touted Cannabis Number?
Investing
Should You Bet on Wine or Weed Stocks Over the Next Decade?
Dividend Stocks
Do Cannabis Sales Pose a Risk to North America’s Beer Markets?
Investing
3 Growth Stocks in Rising Industries That Can Electrify Your TFSA for the Long Haul
Investing
Could Marijuana Legalization Be Delayed Again?
Investing
The 5-Stock Diversified Portfolio: Where Equity Investors Can Start
Investing
Is Aurora Cannabis Inc. Looking to Make Another Big Acquisition?
Investing
Has the Opportunity for Canopy Growth Corp. Passed?
Investing
At What Price Does Canopy Growth Stock Become a Good Investment?
Investing
Is Canopy Growth Corp. a Steal at Less Than $30?